Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The insulin gene (INS) is a small, protein-coding gene spanning approximately 1,425 base pairs on human chromosome 11. It comprises three exons, two introns, and encodes a 110-amino acid preproinsulin precursor protein that is processed to mature insulin in pancreatic beta cells. The insulin protein is a peptide hormone responsible for regulating glucose, fat, and protein metabolism by promoting glucose uptake into cells. Dominant mutations in the insulin gene can cause neonatal-onset diabetes due to toxic misfolding of proinsulin. While the gene itself is not a direct therapeutic target, its mutations serve as diagnostic biomarkers in select forms of diabetes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin gene (INS).